Company / Depreciation & Amortization
Upstream Bio, Inc. Depreciation & Amortization History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$188.0K
FY2025
5-year range
$60.0K / $188.0K
FY2023-FY2025
Trend
+213.3%
vs FY2024
Sector context
#156 of 168
Health Care
What the data says
Depreciation & Amortization changed +213% YoY in FY2025, a notable deviation from the 2-year average annual change of +107%.
Based on SEC 10-K filings.
$188,000 in FY2025.
Increased from $60,000 to $188,000 over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 168This company $188.0K Sector average $212.9M
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2025, depreciation & amortization increased 213.3% year-over-year.
- Ranks #156 out of 168 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 8.68 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $188.0K | +213.3% |
| FY2024 | $60.0K | +0.0% |
| FY2023 | $60.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026